Title:
MALIGNANT MESOTHELIOMA THERAPEUTIC AGENT AND MALIGNANT MESOTHELIOMA PATIENT SELECTION METHOD
Document Type and Number:
WIPO Patent Application WO/2022/091809
Kind Code:
A1
Abstract:
The present invention addresses the issue of providing a malignant mesothelioma therapeutic agent and a method for selecting malignant mesothelioma patients. The issue can be solved by a malignant mesothelioma therapeutic agent that includes, as an effective component thereof, a compound that targets the oxytocin receptor.
More Like This:
Inventors:
TANAKA ICHIDAI (JP)
KODAMA YUTA (JP)
KODAMA YUTA (JP)
Application Number:
PCT/JP2021/038161
Publication Date:
May 05, 2022
Filing Date:
October 15, 2021
Export Citation:
Assignee:
NATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP)
International Classes:
A61K45/00; A61K31/40; A61K31/4439; A61K31/495; A61K31/535; A61K31/7105; A61K31/713; A61K33/243; A61K45/06; A61K48/00; A61P35/00; C12Q1/6886; G01N33/68; C12N15/113
Domestic Patent References:
| WO2018022668A2 | 2018-02-01 |
Foreign References:
| JP2009013077A | 2009-01-22 | |||
| JP2014208650A | 2014-11-06 |
Other References:
MADRAZO I.A · FRANCO-BOURLAND R.E.B · LEÓN-MEZA V.M.A · MENA I.A: "Intraventricular somatostatin-14, arginine vasopressin, and oxytocin : analgesic effect in a patient with intractable cancer pain.", PROCEEDINGS OF THE MEETING OF THE AMERICAN SOCIETY FOR STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, vol. 50, no. 1-6, 1 January 1987 (1987-01-01), CH , pages 427 - 431, XP009536176, ISSN: 1011-6125, DOI: 10.1159/000100753
See also references of EP 4238579A4
See also references of EP 4238579A4
Attorney, Agent or Firm:
MATSUMOTO Seiji (JP)
Download PDF:
Previous Patent: SUBSTRATE FOR SEMICONDUCTOR DEVICE
Next Patent: LAMINATED RESIN SHEET FOR MOLDING, AND MOLDED ARTICLE USING SAME
Next Patent: LAMINATED RESIN SHEET FOR MOLDING, AND MOLDED ARTICLE USING SAME